- Author
-
C.I.M. Busard
- Title
- A step towards personalized care for psoriasis
- Supervisors
-
P.I. Spuls
- Co-supervisors
- Award date
- 27 January 2021
- Number of pages
- 223
- Document type
- PhD thesis
- Faculty
- Faculty of Medicine (AMC-UvA)
- Abstract
-
Psoriasis is a chronic inflammatory skin disease which can lead to a significant burden on quality of life. There is no cure yet, but the availability of biologics therapies targeting selective key immune pathways has radically transformed treatment.
This thesis concerns the evaluation of benefits and harms of systemic combination therapy (Part I), examination of biomarkers for treatment with ustekinumab (Part II), and assessment of efficacy and safety of nail psoriasis interventions with a first step towards the development of a core outcome set (Part III).
Part I demonstrated that combination of systemic agents is prescribed regularly among patients with moderate to severe psoriasis. The type of combinations used differs geographically. A specific and promising combination, adalimumab with methotrexate, was investigated with RCT design.
Part II showed a correlation between anti-ustekinumab antibodies and treatment response. Measurement of antibodies against ustekinumab may therefore be considered if treatment response is unsatisfactory. Correlations between ustekinumab trough concentrations or HLA-Cw6 as a pharmacogenetic and treatment response were not detected. Future research on pharmacogenetic markers and immune profiling is desired to optimize personalized care for psoriasis patients.
Data presented in Part III illustrate that there are wide variations in outcome measurements used in RCTs on nail psoriasis, which limits possibility to perform a meta-analysis. As the number of RCTs performed in this field had increased significantly over the last few years witch mainly adds on to evidence for biologic therapies, harmonization of outcomes is urgently needed to reduce waste in research. - Persistent Identifier
- https://hdl.handle.net/11245.1/c54eab61-c68b-4ed0-ab93-5ac416ee6d20
- Downloads
-
Thesis (complete)
Front matter
Chapter 1: General introduction and outline of thesis
Chapter 2: Combined use of systemic agents for psoriasis: A systematic review
Chapter 3: Biologics combined with conventional systemic agents or phototherapy for the treatment of psoriasis: Real-life data from PSONET registries
Chapter 4: Optimizing adalimumab treatment in psoriasis with concomitant methotrexate (OPTIMAP): Study protocol for a pragmatic, single-blinded, investigator-initiated randomized controlled trial
Chapter 5: Adalimumab with methotrexate versus adalimumab monotherapy in psoriasis: First-year results of a randomized controlled trial
Chapter 6: Clinical consequences of antibody formation, serum concentrations, and HLA-Cw6 status in psoriasis patients on ustekinumab
Chapter 7: Reporting of outcomes in randomized controlled trials on nail psoriasis: A systematic review
Chapter 8: Interventions for nail psoriasis: A systematic review
Chapter 9: Discussion
Chapter 10: Summary and conclusion/Samenvatting en conclusie
List of abbreviations; List of contributing authors; List of publications; PhD portfolio; Acknowledgements/Dankwoord; About the author
Disclaimer/Complaints regulations
If you believe that digital publication of certain material infringes any of your rights or (privacy) interests, please let the Library know, stating your reasons. In case of a legitimate complaint, the Library will make the material inaccessible and/or remove it from the website. Please Ask the Library, or send a letter to: Library of the University of Amsterdam, Secretariat, Singel 425, 1012 WP Amsterdam, The Netherlands. You will be contacted as soon as possible.